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Abstract
Background High body mass index (BMI) is associated
with diseases of the hip joint and subsequent total hip
arthroplasty (THA). Less is known about the effects of BMI
on the functional postoperative status after THA in obese
patients. The purpose of this study was therefore to quantify
the role of high preoperative BMI on long-term pain status
and functional outcome after THA.
Methods In a multi-center cohort, study data of 20,553
primary THAs (18,968 patients) and 43,562 postoperative
clinical examinations were analyzed for a follow-up period
of up to 15 years. Patients were classified into three BMI
groups (normal weight <25 kg/m2, overweight 25 to
<30 kg/m2, and obese ≥30 kg/m2), and pain status and
functional outcome were compared accordingly.
Results High preoperative BMI is associated to an almost
perfect dose–effect relationship with decreased ambulation
during a follow-up period of 15 years, but pain relief of
THA is equally efficient for all BMI groups.
Conclusion Overweight and obesity are modifiable risk
factors that may warrant physicians giving recommendations
to patients before or after THA, to improve postoperative
functional outcome quality.
Keywords Hip replacement . Arthroplasty .
Body mass index . Obesity . Outcome research
Introduction
Reducing or eliminating pain and restoring physical func-
tion are the primary goals of total hip arthroplasty (THA).
Knowledge of prognostic factors associated with postoper-
ative outcomes is therefore an important element when
surgeons are advising their patients on the risks and benefits
of THA [1, 2]. Factors that can be modified either by
patients or surgeons to favor better outcomes are of particu-
lar interest in this context. High body weight has been
associated with negative [3, 4] and positive [5] outcomes of
THA. However, quantitative and long-term estimates of
such effects are currently lacking. The purpose of this study
was to quantify the role of high preoperative body mass
index (BMI), as a measure of relative body weight, on long-
term pain status and functional outcome after THA.
Patients and Method
The study was designed as a cohort study based on data from
the total hip registry of the Maurice E. Müller Foundation in
Berne, Switzerland, and on a comparable database main-
tained at the Sunnybrook and Women’s College Health
Sciences Centre in Toronto, Canada. These combined data
sets represent one of the largest databases with pre-, intra-,
and postoperative clinical data on patients with THA. The
data collection was started in 1965 and is still ongoing. Data
are collected using optically readable code sheets according
to the standards of the International Documentation and
Evaluation System (IDES) [6]. The code sheets include
information on demographics, pre- and postoperative
functional status, pain levels of patients, surgical proce-
dures, implant characteristics, and postoperative implant
status with reference to component loosening. Additional
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information is available on implants revised because of
component failure. All data have been collected in multiple
hospitals located in various countries on a voluntary basis.
Baseline information of 18,968 patients older than
20 years with complete preoperative data sets regarding pain
status, walking time without support, hip flexion range, and
preoperative BMI were evaluated. Primary THAs were
performed between 1965 and 2003 in 42 European and
one Canadian hospital. Follow-up data up to postoperative
year 15 totaled 43,562 postoperative clinical examinations.
Bilateral THAwas performed in 7.7% of all THAs. Patients
with radiographic signs of loose prosthetic components,
as well as revision operations, were excluded from the
comparative analysis.
Preoperative BMI was calculated for all patients, based
on weight and body height at admission (calculated as
weight in kilograms divided by the body height in meters
squared). Postoperative pain status and functional outcome
was compared for BMI groups of patients classified
according to National Institutes of Health (Bethesda, MD
20892, USA) as underweight: <18.5 kg/m2; normal weight:
18.5 to <25.0 kg/m2; overweight: 25.0 to <30.0; obese I:
30.0 to <35.0 kg/m2; obese II: 35.0 to <40.0 kg/m2; and
as extremely obese: ≥40 kg/m2. Outcomes were compared
over the entire follow-up period, with formal statistical tests
at years 3, 6, 9, and 12 after THA. For purposes of visuali-
zation, results were also displayed graphically.
All outcome items were recorded on a ordered catego-
rized scale:
– Hip pain: none, mild, moderate, severe, and intolerable.
Walking time without support: >60, 31–60, 10–30,
<10 min, and none. Stair climbing: normal, assisted,
two feet on each step, other method, or not possible.
Hip flexion range: >90, 71–90, 30–70, <30°, stiff.
Difficulties putting on shoes and socks: none, slight,
extreme, unable.
– Hip pain, walking time without support, and hip
flexion range are mandatory fields in IDES forms; that
is, forms with data missing in these fields cannot
be entered into the database. Stair climbing and dif-
ficulties putting on shoes/socks are not defined as
mandatory fields. Data for these indicators were
therefore not always complete. Nonetheless, there
were 39,519 follow-ups where stair-climbing capabil-
ities were recorded. Similarly, 16,319 follow-ups
provided information about the degree of difficulties
with putting on shoes and socks.
For every follow-up year and for each indicator, the
proportion of patients with the most favorable outcome was
analyzed as a binary variable, i.e., the proportion of patients
with no hip pain, with walking time without support
>60 min, with hip flexion range >90°, and with capability
for normal stair climbing and putting on shoes and socks in
a normal way.
Statistical analysis included initial descriptive procedures
for continuous data with the calculation of means with
95% confidence intervals (CI95), medians, and quartiles.
Categorical data were described using proportions with
CI95. Gender- and diagnosis-adjusted associations between
age and BMI at THA were analyzed using linear models.
For graphical comparisons of outcomes, proportions were
directly standardized with reference to gender, age group,
and diagnosis. Age groups were defined based on quartiles
of the observed data (first quartile=58.5 years, median=
66.0 years, third quartile=73.1 years), and diagnoses were
categorized, according to IDES definitions, into osteoar-
thritis, dysplasia, inflammatory arthritis, fracture, and other
diagnoses (osteonecrosis, Paget’s disease, post-septic
arthritis, tumors). The statistical differences of pain and
functional outcomes between BMI groups were assessed,
using multivariate logistic regression separately for follow-
up years 3, 6, 9, and 12. The outcome variables were the
proportions as described above, and the explanatory
variables included BMI groups, gender, age in years at
THA, diagnosis, and clinic where THA was performed.
Relative risks for the best outcome across BMI groups were
calculated with the normal weight group as the reference
group (Table 3). Bonferroni adjustments were used to
address the problem of multiple testing. Preliminary
analyses of patient distribution across BMI groups indicated
low frequencies in groups with extreme BMI (Table 1). The
BMI classification was therefore simplified for statistical
Table 1 Distribution of BMI
classes at primary THA
Data derived from 18,968
patients (7.7% bilateral THA).
BMI Group Frequency Percent 95% Confidence limits
Underweight (<18.5 kg/m2) 354 1.7 1.5–1.9
Normal weight (18.5 to <25.0 kg/m2) 7,469 36.3 35.6–37.1
Overweight (25.0 to <30.0 kg/m2) 8,978 43.7 42.9–44.4
Obese (≥30.0 kg/m2) 3,752 18.3 17.7–18.8
Obese I (30.0 to <35.0 kg/m2) 3,078 15.0 14.4–15.5
Obese II (35.0 to <40.0 kg/m2) 559 2.7 2.5–3.0
Extreme obese (≥40 kg/m2) 115 0.6 0.5–0.7
Total 20,553* 100.00
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analysis as normal weight <25 kg/m2, overweight 25 to
<30 kg/m2, and obese ≥30 kg/m2. Confidence interval
calculation and statistical analyses of differences accounted
for nonindependence of observations in patients with
bilateral THA, using the Taylor expansion method. For all
statistical tests, a level of significance was set at 0.05
throughout the paper, and SAS 9.1 (SAS Institute, Inc.,
Cary, NC, USA) was used for all calculations.
Results
Complete preoperative data and follow-up examinations up
to year 15 amounted to 64,115 records. The distribution of
the initial BMI classes at THA is given in Table 1. The
respective numbers of observations in each aggregated BMI
group before THA and for follow-up years 3, 6, 9, and 12
are given in Tables 2 and 3.
A total of 10,138 female (53.5%) and 8,830 male (46.5%)
patients were included in the study. The average age at THA
was 64.8 years (CI95=65.7–65.0), male patients were on
average 64.1 years old (CI95=63.9–64.3), and females were
65.5 years (CI95=65.3–65.7). Average BMI at THA was
26.49 (CI95=26.42–26.55; median=26.2; first quartile=
23.7, third quartile=29.0). The BMI of female patients was
26.04 (CI95=25.94–26.14); the BMI of male patients was
26.99 (CI95=26.91–27.08) and significantly higher than in
females. No significant difference in BMI was observed
between patients with uni- and bilateral THA. The distribu-
tion of the main diagnoses at THA was osteoarthritis in
76.3% of cases, dysplasia in 8.9%, inflammatory arthritis in
3.8%, fractures in 4.7%, and other diagnoses in 6.3% of
cases (Table 2). The gender-adjusted age at THA, calculated
as least square means obtained from a linear model, was
significantly decreased in obese patients for osteoarthritis,
dysplasia, and inflammatory arthritis, but not for fractures
(Table 2). The effect of BMI on age at THA was, however,
not consistent and nonlinear across diagnostic groups.
The proportions of patients without hip pain at postopera-
tive years 3, 6, 9, and 12 are given in Table 3. The results
Table 2 Distribution of gender-adjusted age (least square means) in years at THA across diagnoses and BMI groups
Diagnosis BMI <25 (normal) BMI 25 to <30 (overweight) BMI≥30 (obese)
N LSM 95% CIa N LSM 95% CIa N LSM 95% CIa
Osteoarthritis 5,296 67.4 67.2–67.7 7,241 60.0 58.5–61.5 3,139 64.9 63.5–66.4
Dysplasia 972 66.7 66.5–66.9 634 53.9 52.6–55.2 221 60.1 57.4–62.8
Inflammatory arthritis 464 65.6 65.2–65.8 266 59.6 57.9–61.2 55 59.5 58.4–60.6
Fracture 544 55.9 55.1–56.7 332 61.9 58.3–65.5 94 60.7 59.5–61.8
Other 548 59.0 58.1–59.9 504 62.5 61.4–63.7 243 60.0 58.3–61.6
Overall 7,824 60.5 60.2–60.8 8,977 60.7 60.4–61.0 3,752 59.6 59.2–60.0
a 95% confidence limits
Table 3 Percentage (±95% confidence limits) of patients without hip pain and with best functional status across BMI groups for follow-up
years–3, 6, 9, and 12
Follow-up
year









3 <25 2,537 79.4 77.8–81.0 63.8 62.0–65.6 85.0 83.6–86.5 80.9 79.3–82.4 75.1 72.1–78.2
25–30 2,884 79.3 77.7–80.8 58.8 57.0–60.6 81.6 80.1–83.2 77.8 76.2–79.4 73.5 70.7–76.4
>30 1,150 78.9 76.5–81.4 49.7b 46.9–52.4 75.1b 72.6–77.6 73.1b 70.5–75.8 61.2b 56.5–66.0
6 <25 1,492 79.5 77.5–81.6 57.9 55.5–60.4 77.8 75.8–79.9 78.4 76.3–80.5 74.4 71.1–77.6
25–30 1,933 80.4 78.6–82.2 54.6 52.5–56.7 72.9 70.9–74.9 76.9 75.0–78.9 69.9 67.1–72.8
>30 828 78.9 76.1–81.8 44.5b 41.3–47.8 64.7b 61.5–68.0 70.2b 67.1–73.3 64.1b 59.7–68.5
9 <25 500 75.5 71.7–79.3 49.6 45.3–53.9 69.3 65.2–73.4 77.3 73.5–81.1 68.7 62.9–74.4
25–30 611 74.2 70.6–77.7 44.4 40.8–48.0 65.7 61.9–69.5 72.7 69.0–76.3 66.0 60.2–71.8
>30 199 76.5 69.8–83.2 38.3b 31.9–44.7 54.8b 47.4–62.2 74.6 68.7–80.5 50.3b 41.3–59.3
12 <25 158 74.6 67.0–82.2 45.3 37.3–53.4 63.4 54.5–72.4 69.3 61.2–77.4 62.9 53.0–72.8
25–30 152 74.4 67.1–81.6 42.0 36.1–47.9 59.2 51.6–66.9 60.6 52.4–68.8 57.5 47.5–67.5
>30 52 81.0 71.2–90.8 22.5b 15.5–29.4 47.3 33.4–61.3 80.9 79.3–82.4 36.8 27.9–45.8
a Sample size for hip pain, walking time without support, and hip flexion range (mandatory fields in the IDES sheets).
b Significant difference ( p<0.05, multivariate logistic regression) from the normal BMI group (<25 kg/m2 ).
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indicate no significant differences between BMI groups for
postoperative pain for the entire follow-up period.
Walking Time Without Support
The proportions of patients capable of walking more than
1 h at postoperative years 3, 6, 9, and 12 are given in
Table 3. The standardized proportions across preoperative
BMI groups and follow-up time are shown as percentages
in Fig. 1. The highest prevalence of cases with the best
walking capacity was observed during postoperative
years 3–6. Compared to normal weight patients (BMI<25),
obese patients (BMI>30) had consistently poorer walking
capacities. Statistically significant differences between the
normal and obese group were observed up to postoperative
year 12. The differences in walking time between groups
appeared parallel up to year 10 after THA. Postoperative
differences in the proportions of patients capable of walking
more than 1 h between these two BMI groups were in the
range of 9–21%. Overweight patients also had consistently
lower walking capacities. Differences with the normal
weight group were, however, not significant for any of the
follow-up years 3, 6, 9, and 12.
The crude and standardized data for ascending and
descending stairs are given in Table 3 and Fig. 2. The
proportion of patients without any impairment in walking
up stairs reached its peak during years 2–4 after THA and
declined almost in parallel for all BMI groups. The
differences in the proportions were significant between the
obese and the normal weight group. Similarly consistent
but not significant differences were observed between the
overweight and the normal weight group.
The crude proportion of patients with hip flexion range
greater than 90° is shown in Table 3. Hip flexion range was
above 90° for more than 70% of all patients in all BMI
groups, up to postoperative year 6, but the number of cases
with the best flexion range in the obese group was signi-
ficantly lower than in the normal weight group. Consistent
differences were seen between overweight and normal
weight groups, but they were not statistically significant.
Fig. 1 Standardized proportions
of patients with walking time
without support >60 min
Fig. 2 Standardized proportions
of patients capable of normal
stair climbing
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Discussion
There is high evidence that obesity is a risk factor for
osteoarthritis and subsequent THA [7–11]. In addition,
obesity was also identified as a risk factor for intra- and
postoperative complications in THA [12]. However, there is
little information available on the effects of preoperative
obesity on postoperative pain and functional status after
THA [3, 5]. Postoperative hip pain and functional status
were therefore studied in a large cohort of THA patients
over a follow-up period of 15 years.
Overweight and obesity are often associated with a
variety of additional health problems [13, 14] that may
secondarily affect physical function. Furthermore, degenera-
tive joint diseases have detrimental effects on other weight-
bearing joints and may thus severely affect mobility. The
strengths of this study include a possible generalization of
the results based on the multi-center nature of the evaluation
and the large number of patients and clinical follow-up
examinations over a long period of time. Furthermore,
the multivariate approach in analyzing the data allowed
accounting for effects of confounding factors associated with
both outcome and BMI. We therefore consider the results to
be applicable to a broad range of patients, irrespective of
their age, gender, diagnosis, and factors related to surgical
procedures and implants.
Our data support the findings of other studies stating that
the probability of developing osteoarthritis with resulting
THA is significantly increased in obese patients [8, 10, 15,
16]. Interestingly, obese patients need THA younger than
normal weight patients in the diagnostic groups of osteoar-
thritis, dysplasia, and inflammatory arthritis, but not for
fractures. The older age at THA for the diagnostic group of
fractures for obese patients may also indicate some preven-
tive effects of obesity, possibly associated with lower levels
of physical activity and lower incidence of osteoporosis
in such patients. These findings support the hypothesis of
Taylor et al. [17], who found a positive correlation between
low BMI and increased risk of femoral neck fractures.
There exists only one recent study comparing pain
reduction after THA in an obese patients group (BMI>30,
n=89) against a non-obese patients group (BMI<30, n=99)
[18] with no statistical difference after a mean follow-up of
14.5 years. The authors found a complete and long-lasting
relief of pain for 70–80% of all patients. This was
irrespective of their preoperative BMI over the entire
follow-up period of 15 years. High BMI is therefore an
irrelevant prognostic factor for postoperative pain relief.
The results confirm the fast alleviation of pain after surgery
and the high efficacy of THA in therapy and rehabilitation
of disabling disorders of the hip joint.
Furthermore, to our knowledge, this is the first large
cohort study showing that high preoperative BMI is
associated in an almost perfect dose–effect relationship
with decreased ambulation during the entire follow-up
period. Maximal outcomes for ambulation (walking without
support and climbing/descending stairs) of obese patients
were consistently 10–20% below normal weight patients
(Figs. 1 and 2). The data show that peak postoperative
walking capacities are reached only 2 to 3 years after THA
and remain on a plateau until year 5. No such plateau phase
is seen for climbing and descending stairs, most likely
because of the fact that climbing or descending stairs is
a less demanding task than walking for more than 1 h.
Furthermore, there are no indications of delayed postopera-
tive mobilization in the overweight or obese patient group
or of differences in the course of loss of mobilization with
increasing postoperative time.
Differences in hip flexion range between BMI groups are
less compelling than outcomes directly related to ambula-
tion, and there is no consistent dose–effect relationship after
postoperative year 7. It appears therefore that detrimental
effects of high BMI on physical function are not directly
linked to the biomechanical functionality and flexibility of
the hip joint itself, but to the overall agility and mobility of
patients. This impression is consistent with the findings
regarding the ability to put on shoes and socks, where obese
and overweight patients have consistently poorer outcomes
during the entire follow-up period, although unimpaired
hip flexion range is a prerequisite for putting on shoes
and socks.
It can be argued that the overall physical performance of
overweight and obese patients is already generally poor
before THA and that postoperative functional improvement
is regained only in relation to the preoperative status.
However, according to the results of this study, BMI is a
significant factor associated with poor functional outcome
that could be influenced preoperatively [19]. Furthermore,
loosing weight has numerous other health benefits, includ-
ing fewer perioperative complications [20]. On the other
hand, it has to be stressed that the most important goal of
implanting an artificial hip joint, which is pain reduction, is
accomplished in obese patients similarly as in the normal
weight group. These facts might warrant some additional
recommendations given to patients by physicians before
THA, to reduce perioperative risks and improve postopera-
tive outcome quality.
Conclusion
Overweight and obesity, in particular, are modifiable
risk factors that not only play a deleterious role in the
pathogenesis of osteoarthritis, but also affect physical
outcome after THA. It is therefore important that surgeons
inform patients about the negative consequences of high
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preoperative bodyweight on restoring physical function
after THA and that they emphasize pre- or postoperative
weight control programs. On the other hand, it has to be
stressed that THA is equally efficient for pain relief in all
BMI groups.
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